Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-078956
Filing Date
2025-05-29
Accepted
2025-05-29 16:12:06
Documents
1
Period of Report
2025-05-28

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4017
  Complete submission text file 0000950170-25-078956.txt   5446
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 85 WELLS AVENUE SUITE 210 NEWTON MA 02459
Business Address
Oliger Christy J. (Reporting) CIK: 0001822092 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 251003489